US 7718769
Tri-peptide hepatitis C serine protease inhibitors
granted A61KA61K38/00
Quick answer
US patent 7718769 (Tri-peptide hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00